KALA BIO
KALA
54 hedge funds and large institutions have $353M invested in KALA BIO in 2017 Q3 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.03% more ownership
Funds ownership: 0% → 0.03% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$74.5M |
| 2 |
O
OrbiMed
New York
|
+$52.2M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$46.4M |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
+$41.5M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$25.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRSOTSOK
51
Teachers Retirement System of the State of Kentucky
Frankfort,
Kentucky
| $105K | +$110K | +2 | New |
|
|
SO
52
STRS Ohio
Columbus,
Ohio
| $54K | +$54.9K | +1 | New |
|
53
UBS Group
Zurich,
Switzerland
| $54K | +$54.9K | +1 | New |
|
|
IUHSA
54
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| $48K | – | – | – |
|
55
Legal & General Group
London,
United Kingdom
| $43K | +$54.9K | +1 | New |
|
|
FPFS
56
First Personal Financial Services
Charlotte,
North Carolina
| $22K | – | – | – |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| $17K | – | – | – |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| $15K | – | – | – |
|
|
CCM
59
Covington Capital Management
Los Angeles,
California
| $9K | – | – | – |
|
60
BNP Paribas Financial Markets
Paris,
France
| $4.93K | – | – | – |
|
KALA Hedge Fund Activity: Q3 2017 in Review
54 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2017, worth a combined $353M.
Buyers outnumbered sellers: 54 funds opened new KALA positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $74.5M.
- 54 institutional investors held KALA BIO (KALA) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $353M of KALA BIO stock for Q3 2017.
- 54 funds opened new KALA BIO positions in Q3 2017 and 0 closed out, a net change of +54 holders.
- The largest KALA BIO buyer in Q3 2017 was Wellington Management Group, an estimated $74.5M added.
Based on aggregated 13F filings for Q3 2017.